Hair Loss treatment CB-03-01 powder 19608-29-8 CB03-01 CAS NO.19608-29-8
- FOB Price: USD: 55.00-55.00 /Metric Ton Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: L/C,D/A,D/P,T/T,Other
- Available Specifications:
99% purity(1-10)Metric Ton
- Product Details
Keywords
- CB-03-01
- cb0301
- anti hair loss
Quick Details
- ProName: Hair Loss treatment CB-03-01 powder 19...
- CasNo: 19608-29-8
- Molecular Formula: C24H34O5
- Appearance: powder
- Application: anti hair loss
- DeliveryTime: 12-15 days
- PackAge: Foil Bag, According to Client's Requir...
- Port: SHANGHAI
- ProductionCapacity: 10000 Kilogram/Week
- Purity: 99%
- Storage: store in cool and dry place
- Transportation: FedEx DHL EMS or by Sea
- LimitNum: 1 Gram
Superiority
1, High quality with competitive price:
1) Standard:BP/USP/EP/Enterprise standard
2) All Purity≥99%
3) We are manufacturer and can provide high quality products with factory price.
2, Fast and safe delivery
1) Parcel can be sent out in 24 hours after payment.Tracking number available
2) Secure and discreet shipment.Various transportation methods for your choice.
3) Customs pass rate ≥99%
4) We have our own agent/remailer/distributor who can help us ship our products very fast and safe,
and we have stock in there for transferring.
3,We have clients throughout the world.
1) Professional service and rich experience make customers feel at ease, adequate stock and fast delivery meet their desire.
2) Market feedback and goods feedback will be appreciated, meeting customers's requirement is our responsibility.
14) High quality,competitive price,fast delivery ,first-class service gain the trust and praise from the customers.
Details
CB-03-01 is the drug for the treatment of hair loss dwindled. It has same function and application with RU58841 and Setipiprant.
CB-03-01 is a molecule that acts at the level of the skin. The molecule has a unique mechanism that acts at the skin surface, and is quickly metabolized to free inactive cortexolone, a substance naturally found in the body. The molecule has been evaluated in a variety of animal models as well as initial human trials in Europe. The results of these studies demonstrate that CB-03-01 appears to have potent activity without significant local or systemic side effects.